Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
For people with an SDHD mutation who develop paraganglioma, the risk of metastasis appears to be low, around 4% in one meta-analysis, much lower than for SDHB mutations [6].
Some inherited gene mutations can raise the risk of both paraganglioma and thyroid cancer, but the sources do not show that paraganglioma directly causes thyroid cancer lymph…
Yes. SDHD mutations are a major cause of hereditary paragangliomas, and carriers often develop multiple tumors, with penetrance rising with age [5][6][7].
Small pilot trials in STEMI patients suggest ticagrelor monotherapy right after primary PCI may reduce bleeding without a clear rise in ischemic events, but the evidence is too…
Yes. A large randomized trial found that a pressure optimization protocol during primary PCI for STEMI improved reperfusion success compared with conventional rapid…
CLDN18.2 is found in roughly 30% to 34% of gastric adenocarcinoma patients when using the stricter clinical cutoff, though rates vary by threshold and population [4][6].
Yes. Adding immune checkpoint inhibitors to chemotherapy improves pathological response rates in gastric adenocarcinoma, though the survival benefit is less consistent.
Yes. A 2023 study at Cayenne Hospital in French Guiana found H. pylori in 34.3% of patients tested, and H. pylori is a well-established major risk factor for gastric…
Some evidence links GLP-1 receptor agonists to a modest increase in early-stage diabetic retinopathy, but findings are mixed and may depend on the specific drug and how quickly…
There is no direct evidence that Ganoderma lucidum polysaccharides treat diabetic retinopathy; one review found they promote angiogenesis (new blood vessel growth), which could…
Early animal and lab studies suggest Euonymus alatus extracts and one of its compounds may slow diabetic retinopathy by blocking abnormal blood vessel growth, but human evidence…
Muscle energy techniques may help reduce muscle tone, improve range of motion, and support function in post-stroke spasticity, but the evidence is early and comes mainly from…
Acupuncture has shown good therapeutic potential for managing post-stroke spasticity, with various types of acupuncture being studied for their effectiveness.
There is no single cure for Epstein-Barr virus (EBV); treatment depends on what the virus is doing, ranging from supportive care for mild illness to antivirals, immune therapies…
Yes. Fluorescence-guided imaging is already used in veterinary surgical oncology to help find and remove tumors, though it is not perfect and can miss or falsely flag tissue…
The CXCL16/CXCR6 axis acts as a "double-edged sword" in cancer, where it can either promote tumor growth and drug resistance or be targeted to inhibit tumor progression.
A single case report links pazopanib and axitinib to probable cholecystitis in a kidney cancer patient, but this is rare and based on limited evidence [1].
The aryl hydrocarbon receptor (AhR) can contribute to liver injury through oxidative stress, but it also protects the liver in other contexts, so its role is dual and depends on…
CMV treatment relies on antivirals like valganciclovir, letermovir, and maribavir, plus experimental options such as artesunate, which differs from how many other viruses are…
Artesunate kills cytomegalovirus in the lab, including drug-resistant strains, but clinical evidence in immunocompromised patients is limited and mixed, with viral load drops…
The sources do not directly measure outcomes of integrating mental health screening into NCD care; they show related tools (digital health, lifestyle medicine, chatbots) have…
Treatment for EBV-triggered HLH usually combines HLH-directed therapy (dexamethasone, etoposide, cyclosporine, or ruxolitinib) with measures to control the EBV infection and any…
Yes. In dermatomyositis, being male and being older are both linked to higher risk of lung disease, especially rapidly progressive interstitial lung disease in anti-MDA5-positive…
Yes. In a phase 3 trial, brepocitinib 30 mg improved the Total Improvement Score in adults with dermatomyositis compared with placebo over 52 weeks [3][6].
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.